Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aquaporin channels are a family of small, integral membrane proteins—classified as water channels—that form pores in biological cell membranes, facilitating fast and selective transport of water, and in some cases glycerol and other small solutes, down osmotic gradients[1][2][6]. Structurally, they are characterized by six transmembrane α-helices and a conserved Asn-Pro-Ala (NPA) motif, assembling as tetramers in cellular membranes with each monomer functioning independently as a pore[1][3][4][6]. The family contains water-specific aquaporins and aquaglyceroporins (which also conduct glycerol), with a signature “hourglass” fold that imparts strict selectivity for water (or water/glycerol) while excluding protons and ions[1][5][6]. Aquaporins play essential roles in physiological processes such as renal water reabsorption, brain fluid regulation, and glandular secretion. Dysregulation or mutation of specific aquaporins has been implicated in diseases ranging from congenital nephrogenic diabetes insipidus to brain edema and neuromyelitis optica[6]. While considered attractive therapeutic targets, especially for CNS or renal indications, the development of potent, specific aquaporin-modulating drugs remains an ongoing challenge[6].
Inhibition of water permeability (by blocking channel function or by reducing aquaporin membrane expression) Modulation of trafficking (regulating expression or localization in the membrane)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aquaporin channel (AQP (for individual family members, e.g., AQP1, AQP4)).